Loading...
Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy
Patients with hepatocellular carcinoma (HCC) often experience hepatic morbidity. Hepatitis B virus (HBV) reactivation is well documented as a serious hepatic morbidity during anti-cancer therapy. Reported rates of HBV reactivation in chronic carriers with HCC undergoing chemotherapy range from 4%-67...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069296/ https://ncbi.nlm.nih.gov/pubmed/24976705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7675 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|